Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
Open Access
- 13 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-13
Abstract
Aim: The aim of the study was to discover the metabolomic changes in plasma that occur during human Ischemia-Reperfusion (I/R) injury and to evaluate the diagnostic utility of plasma metabolomic biomarkers for determination of myocardial injury. Deciphering the details of plasma metabolome in ST-segment elevation myocardial infarction (STEMI) patients before and after primary percutaneous coronary interventions (PPCI) would allow for better understanding of the mechanisms involved during acute myocardial ischemia and reperfusion in humans. We performed a detailed non-targeted metabolomic analysis of plasma from 27 STEMI patients who had undergone PPCI in the first 48 hrs employing a LC-MS approach. Plasma metabolome at ischemic condition was compared to multiple time points after PPCI which allowed us to focus on changes in the reperfusion phase. Classification of the differential metabolites based on chemical taxonomy identified a major role for lipids and lipid-derived molecules. Biochemical pathway analysis identified valine, leucine and isoleucine biosynthesis, vitamin B6 metabolism and glutathione metabolism as the most significant metabolic pathways representing early response to I/R injury. We also identified phenyl alanine, tyrosine, linoleic acid and glycerophospholipid metabolism as the most significant pathways representing late response to I/R injury. A panel of three metabolites pentadecanoic acid, linoleoyl carnitine and 1-linoleoylglycerophosphocholine was discovered to have diagnostic value in determining the extent of I/R injury based on cardiac biomarkers. Using a non-targeted LC-MS approach, we have successfully generated the most comprehensive data to date on significant changes in the plasma metabolome in STEMI patients who had undergone PPCI in the first 48 hrs showing that lipid metabolites represent the largest cohort of molecules undergoing significant change.Keywords
Funding Information
- Research Manitoba
- Heart and Stroke Foundation of Canada
This publication has 46 references indexed in Scilit:
- MetPA: a web-based metabolomics tool for pathway analysis and visualizationBioinformatics, 2010
- Correct Use of Repeated Measures Analysis of VarianceAnnals of Laboratory Medicine, 2009
- Silent myocardial ischemia is associated with altered plasma phospholipidsJournal of Clinical Laboratory Analysis, 2009
- Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brainJournal of Lipid Research, 2008
- A correlation network approach to metabolic data analysis for tomato fruitsEuphytica, 2008
- STITCH: interaction networks of chemicals and proteinsNucleic Acids Research, 2007
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006
- Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent proceduresJACC, 2004